Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

28.980
+1.4205.15%
Volume:17.30K
Turnover:494.10K
Market Cap:3.88B
PE:-26.11
High:29.500
Open:27.600
Low:27.100
Close:27.560
52wk High:33.800
52wk Low:13.480
Shares:134.00M
HK Float Shares:134.00M
Volume Ratio:5.06
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.110
ROE:-27.27%
ROA:-12.63%
PB:5.25
PE(LYR):-26.11
PS:45482.11

Loading ...

Hanx Biopharmaceuticals Files HKEX Next-day Return Disclosing Share Buyback at HKD 28.63 Each

Reuters
·
Jul 09

HANXBIO-B Executes Share Buyback, Spending HK$980,100

Stock News
·
Jul 08

HANXBIO-B Repurchases 33,800 H Shares on 8 July, Treasury Stock Increases to 1.84 Million

Bulletin Express
·
Jul 08

HANXBIO-B (03378) Repurchases 21,000 Shares for HK$607,000 on July 7

Stock News
·
Jul 07

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 28.91 Avg Price

Reuters
·
Jul 07

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

Stock News
·
Jul 07

Hanx Biopharmaceuticals partners with HUST Advanced Interdisciplinary Research Centre to establish AI-driven drug-discovery lab

Bulletin Express
·
Jul 07

Hanx Biopharmaceuticals Posts Announcement on Ai-driven Drug Discovery Collaboration

Reuters
·
Jul 07

Hanx Biopharmaceuticals (wuhan) Co - Enters Agreement to Establish Joint Ai-driven Drug Discovery Lab

THOMSON REUTERS
·
Jul 07

Hanx Biopharmaceuticals (wuhan) Co - Collaborates with Hust-cityu Macau Institute Advanced Interdisciplinary Research Centre

THOMSON REUTERS
·
Jul 07

HANXBIO-B Repurchases 29,500 Shares for HK$854,500

Stock News
·
Jul 06

HANXBIO-B repurchases 29,500 H-shares for HKD 0.85 million, treasury stock climbs to 1.79 million shares

Bulletin Express
·
Jul 06

HANXBIO-B Buys Back 48,700 H Shares for HKD 1.40 Million; Treasury Stock Rises to 1.76 Million Shares

Bulletin Express
·
Jul 03

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 28.68 Avg

Reuters
·
Jul 03

Hanx Biopharma Launches AI Drug Development Collaboration With TwinEdge

MT Newswires Live
·
Jul 03

Hanx Biopharmaceuticals (wuhan) and Twinedge Bioscience Initiates Research Collaboration

Reuters
·
Jul 03

HANXBIO collaborates with Switzerland’s TwinEdge Bioscience to deploy AI-powered “Digital Twin” research for core bispecific antibody HX009

Bulletin Express
·
Jul 02

Hanx Biopharmaceuticals Partners with Twinedge Bioscience on Ai-driven HX009 Development

Reuters
·
Jul 02

Hanx Biopharmaceuticals (wuhan) Co - Collaboration Leverages AI for Translational Research on Hx009

THOMSON REUTERS
·
Jul 02

HANXBIO-B repurchases 16,000 H-shares; treasury stock rises to 1.71 million

Bulletin Express
·
Jul 02